|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
134,746,000 |
Market
Cap: |
1.53(B) |
Last
Volume: |
3,983,089 |
Avg
Vol: |
3,971,880 |
52
Week Range: |
$10.31 - $14.99 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 457 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Dynavax Technologies is a commercial stage biopharmaceutical company engaged in developing and commercializing vaccines. Co.'s primary marketed product, Hepatitis B Vaccine (Recombinant), Adjuvanted (HEPLISAV-B), is approved in the U.S. and European Union for prevention of infection caused by known subtypes of hepatitis B virus in adults age 18 years and older. Co. also manufactures and sells CpG oligonucleotide (CpG) 1018 adjuvant, the vaccine adjuvant used in HEPLISAV-B. Co. developed CpG 1018 adjuvant to provide an increased vaccine immune response.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
20,526 |
71,026 |
3,241,429 |
7,930,135 |
Total Sell Value |
$262,322 |
$986,072 |
$41,921,797 |
$106,117,062 |
Total People Sold |
1 |
3 |
4 |
6 |
Total Sell Transactions |
1 |
5 |
18 |
31 |
End Date |
2024-01-18 |
2023-10-17 |
2023-04-18 |
2022-04-18 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Slebir John L |
SVP General Counsel |
|
2024-03-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
10,085 |
|
-9% |
|
Burgess Justin |
Chief Accounting Officer |
|
2024-03-01 |
4 |
S |
$12.78 |
$262,322 |
D/D |
(20,526) |
0 |
|
10% |
|
Burgess Justin |
Chief Accounting Officer |
|
2024-03-01 |
4 |
OE |
$9.41 |
$74,232 |
D/D |
7,101 |
20,526 |
|
- |
|
Burgess Justin |
Chief Accounting Officer |
|
2024-02-16 |
4 |
D |
$12.41 |
$29,511 |
D/D |
(2,378) |
13,425 |
|
- |
|
Burgess Justin |
Chief Accounting Officer |
|
2024-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,667 |
15,803 |
|
- |
|
Novack David F |
President & COO |
|
2024-02-15 |
4 |
A |
$9.45 |
$11,406 |
D/D |
1,207 |
22,090 |
|
- |
|
Spencer Ryan |
CEO and Director |
|
2024-02-15 |
4 |
A |
$9.45 |
$3,799 |
D/D |
402 |
201,030 |
|
- |
|
Janssen Robert |
SVP and CMO |
|
2024-02-12 |
4 |
D |
$12.82 |
$19,627 |
D/D |
(1,531) |
58,684 |
|
- |
|
Novack David F |
President & COO |
|
2024-02-12 |
4 |
D |
$12.82 |
$40,396 |
D/D |
(3,151) |
20,883 |
|
- |
|
Burgess Justin |
Chief Accounting Officer |
|
2024-02-12 |
4 |
D |
$12.82 |
$32,037 |
D/D |
(2,499) |
9,136 |
|
- |
|
Spencer Ryan |
CEO and Director |
|
2024-02-12 |
4 |
D |
$12.82 |
$149,789 |
D/D |
(11,684) |
200,628 |
|
- |
|
Macdonald Kelly |
SVP and CFO |
|
2024-02-12 |
4 |
D |
$12.82 |
$38,268 |
D/D |
(2,985) |
4,707 |
|
- |
|
Janssen Robert |
SVP and CMO |
|
2024-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,333 |
60,215 |
|
- |
|
Novack David F |
President & COO |
|
2024-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,833 |
24,034 |
|
- |
|
Burgess Justin |
Chief Accounting Officer |
|
2024-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,667 |
11,635 |
|
- |
|
Spencer Ryan |
CEO and Director |
|
2024-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,833 |
212,312 |
|
- |
|
Macdonald Kelly |
SVP and CFO |
|
2024-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,333 |
7,692 |
|
- |
|
Janssen Robert |
SVP and CMO |
|
2024-02-05 |
4 |
D |
$10.36 |
$41,885 |
D/D |
(4,043) |
55,882 |
|
- |
|
Novack David F |
President & COO |
|
2024-02-05 |
4 |
D |
$12.79 |
$85,540 |
D/D |
(6,688) |
15,201 |
|
- |
|
Burgess Justin |
Chief Accounting Officer |
|
2024-02-05 |
4 |
D |
$12.79 |
$44,100 |
D/D |
(3,448) |
4,968 |
|
- |
|
Spencer Ryan |
CEO and Director |
|
2024-02-05 |
4 |
D |
$12.79 |
$219,080 |
D/D |
(17,129) |
191,479 |
|
- |
|
Spencer Ryan |
CEO and Director |
|
2024-02-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
29,750 |
208,608 |
|
- |
|
Janssen Robert |
SVP and CMO |
|
2024-02-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
59,925 |
|
- |
|
Novack David F |
President & COO |
|
2024-02-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,500 |
21,889 |
|
- |
|
Burgess Justin |
Chief Accounting Officer |
|
2024-02-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,416 |
8,416 |
|
- |
|
423 Records found
|
|
Page 1 of 17 |
|
|